CCR4 chemokine antagonists (Amgen)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCCR4 chemokine antagonists (Amgen)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 4 antagonists
TargetsC-C chemokine receptor type 4
Therapy Area/IndicationsDermatitis, AtopicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmgen Inc
Active IndicationsN/A
Inactive IndicationsDermatitis, AtopicAsthma

Other Information

ATC CodeN/A
Related LinksN/A